United States  

Remdesivir shows modest benefits in coronavirus trial

Seattle Times Thursday, 30 April 2020
Modest results from a federal trial of an experimental drug helped send the stock market soaring on Wednesday, another sign of the desperation for a viable treatment against the coronavirus. Just before markets opened, Gilead, maker of the antiviral drug remdesivir, announced that it was “aware of positive data” about the drug’s performance in a […]
0
shares
ShareTweetSavePostSend
 
Video Credit: KTNV Channel 13 Las Vegas - Published
News video: Remdesivir trial shows it is an effective treatment

Remdesivir trial shows it is an effective treatment 00:38

The first results of the experimental drug - remdesivir - shows that it has the ability to speed up recovery from coronavirus by 31%. Scientists say this is an important proof of concept that a drug can block this virus.

You Might Like


Related videos from verified sources

Massachusetts coronavirus patient says he is living proof that remdesivir works [Video]

Massachusetts coronavirus patient says he is living proof that remdesivir works

He says he wanted to give up his fight against COVID-19 at one point before he took part in the clinical trial that helped save his life.

Credit: WCVB     Duration: 01:58Published
UCHealth part of remdesivir clinical trial to determine how long experimental drug should be used [Video]

UCHealth part of remdesivir clinical trial to determine how long experimental drug should be used

Colorado hospitals are doing their part in determining just how effective the experimental drug remdesivir can be against COVID-19.

Credit: 7News - The Denver Channel     Duration: 02:54Published
Trial Reveals Positive Indications About Possible Coronavirus Treatment [Video]

Trial Reveals Positive Indications About Possible Coronavirus Treatment

There are positive indications about a drug that could possibly treat the coronavirus; CBS2's Dick Brennan reports.

Credit: CBS 2 New York     Duration: 02:04Published

Related news from verified sources

Gilead Sciences' remdesivir could get US emergency approval for coronavirus treatment

Gilead Sciences Inc’s (NASDAQ:GILD) antiviral candidate remdesivir is reportedly getting emergency-use authorisation by the US Food and Drug Administration...
Proactive Investors

Gilead's coronavirus drug remdesivir: Here's what to know

Hopes are high for antiviral drug after a clinical trial showed promise, but the benefits may be limited, experts say.
CBS News


Tweets about this